New Perspectives in Skin Cancer: From Biology to Therapy
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 15 June 2026 | Viewed by 1093
Special Issue Editor
Special Issue Information
Dear Colleagues,
Skin cancer represents the most frequently diagnosed malignancy worldwide, with both melanoma and non-melanoma skin cancers showing a striking and continuous increase in incidence and prevalence over recent decades. This rapid rise constitutes a growing global health burden, driven by demographic changes, ultraviolet exposure, and improved awareness and detection. In parallel, the past few years have witnessed substantial progress in our understanding of skin tumor biology, as well as major advances in early diagnostic strategies and therapeutic approaches. Notably, the introduction of targeted therapies and immunotherapies has significantly improved clinical outcomes for selected patient groups.
This Special Issue of Cancers aims to cover the full spectrum of skin cancer research, from molecular and cellular mechanisms of carcinogenesis to innovations in early diagnosis, prognostic assessment, and state-of-the-art therapeutic strategies. We welcome original research and reviews that contribute to this rapidly evolving field.
Dr. Marija Buljan
Guest Editor
Nika Filipović
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- skin cancer
- melanoma and non-melanoma skin cancer
- tumor biology
- early diagnosis
- targeted therapy
- immunotherapy
- epidemiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
